105 related articles for article (PubMed ID: 16199219)
1. Differential activation of LFA-1 and Mac-1 ligand binding domains.
Walters SE; Tang RH; Cheng M; Tan SM; Law SK
Biochem Biophys Res Commun; 2005 Nov; 337(1):142-8. PubMed ID: 16199219
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain.
Kallen J; Welzenbach K; Ramage P; Geyl D; Kriwacki R; Legge G; Cottens S; Weitz-Schmidt G; Hommel U
J Mol Biol; 1999 Sep; 292(1):1-9. PubMed ID: 10493852
[TBL] [Abstract][Full Text] [Related]
3. Rolling adhesion of alphaL I domain mutants decorrelated from binding affinity.
Pepper LR; Hammer DA; Boder ET
J Mol Biol; 2006 Jun; 360(1):37-44. PubMed ID: 16813834
[TBL] [Abstract][Full Text] [Related]
4. Model of the alphaLbeta2 integrin I-domain/ICAM-1 DI interface suggests that subtle changes in loop orientation determine ligand specificity.
Legge GB; Morris GM; Sanner MF; Takada Y; Olson AJ; Grynszpan F
Proteins; 2002 Aug; 48(2):151-60. PubMed ID: 12112684
[TBL] [Abstract][Full Text] [Related]
5. NMR solution structure of the inserted domain of human leukocyte function associated antigen-1.
Legge GB; Kriwacki RW; Chung J; Hommel U; Ramage P; Case DA; Dyson HJ; Wright PE
J Mol Biol; 2000 Feb; 295(5):1251-64. PubMed ID: 10653701
[TBL] [Abstract][Full Text] [Related]
6. Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins.
Kim M; Carman CV; Springer TA
Science; 2003 Sep; 301(5640):1720-5. PubMed ID: 14500982
[TBL] [Abstract][Full Text] [Related]
7. Promotion of leukocyte adhesion by a novel interaction between vitronectin and the beta2 integrin Mac-1 (alphaMbeta2, CD11b/CD18).
Kanse SM; Matz RL; Preissner KT; Peter K
Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2251-6. PubMed ID: 15458976
[TBL] [Abstract][Full Text] [Related]
8. Shape and shift changes related to the function of leukocyte integrins LFA-1 and Mac-1.
Hogg N; Leitinger B
J Leukoc Biol; 2001 Jun; 69(6):893-8. PubMed ID: 11404373
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of cation binding to the I domains of LFA-1 and MAC-1. The LFA-1 I domain contains a Ca2+-binding site.
Griggs DW; Schmidt CM; Carron CP
J Biol Chem; 1998 Aug; 273(34):22113-9. PubMed ID: 9705356
[TBL] [Abstract][Full Text] [Related]
10. NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding.
Huth JR; Olejniczak ET; Mendoza R; Liang H; Harris EA; Lupher ML; Wilson AE; Fesik SW; Staunton DE
Proc Natl Acad Sci U S A; 2000 May; 97(10):5231-6. PubMed ID: 10805782
[TBL] [Abstract][Full Text] [Related]
11. The alpha subunit cytoplasmic domain regulates the assembly and adhesiveness of integrin lymphocyte function-associated antigen-1.
Lu CF; Springer TA
J Immunol; 1997 Jul; 159(1):268-78. PubMed ID: 9200463
[TBL] [Abstract][Full Text] [Related]
12. LFA-1 and Mac-1 integrins bind to the serine/threonine-rich domain of thrombomodulin.
Kawamoto E; Okamoto T; Takagi Y; Honda G; Suzuki K; Imai H; Shimaoka M
Biochem Biophys Res Commun; 2016 May; 473(4):1005-1012. PubMed ID: 27055590
[TBL] [Abstract][Full Text] [Related]
13. Specific activation of leukocyte beta2 integrins lymphocyte function-associated antigen-1 and Mac-1 by chemokines mediated by distinct pathways via the alpha subunit cytoplasmic domains.
Weber KS; Klickstein LB; Weber C
Mol Biol Cell; 1999 Apr; 10(4):861-73. PubMed ID: 10198043
[TBL] [Abstract][Full Text] [Related]
14. Comparative normal mode analysis of LFA-1 integrin I-domains.
Gaillard T; Martin E; San Sebastian E; Cossío FP; Lopez X; Dejaegere A; Stote RH
J Mol Biol; 2007 Nov; 374(1):231-49. PubMed ID: 17919656
[TBL] [Abstract][Full Text] [Related]
15. Folding and function of I domain-deleted Mac-1 and lymphocyte function-associated antigen-1.
Yalamanchili P; Lu C; Oxvig C; Springer TA
J Biol Chem; 2000 Jul; 275(29):21877-82. PubMed ID: 10764808
[TBL] [Abstract][Full Text] [Related]
16. Interaction between single molecules of Mac-1 and ICAM-1 in living cells: an atomic force microscopy study.
Yang H; Yu J; Fu G; Shi X; Xiao L; Chen Y; Fang X; He C
Exp Cell Res; 2007 Oct; 313(16):3497-504. PubMed ID: 17803991
[TBL] [Abstract][Full Text] [Related]
17. Reversibly locking a protein fold in an active conformation with a disulfide bond: integrin alphaL I domains with high affinity and antagonist activity in vivo.
Shimaoka M; Lu C; Palframan RT; von Andrian UH; McCormack A; Takagi J; Springer TA
Proc Natl Acad Sci U S A; 2001 May; 98(11):6009-14. PubMed ID: 11353828
[TBL] [Abstract][Full Text] [Related]
18. Effect of integrin beta 2 subunit truncations on LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) assembly, surface expression, and function.
Tan SM; Hyland RH; Al-Shamkhani A; Douglass WA; Shaw JM; Law SK
J Immunol; 2000 Sep; 165(5):2574-81. PubMed ID: 10946284
[TBL] [Abstract][Full Text] [Related]
19. Distinct binding affinities of Mac-1 and LFA-1 in neutrophil activation.
Li N; Mao D; Lü S; Tong C; Zhang Y; Long M
J Immunol; 2013 Apr; 190(8):4371-81. PubMed ID: 23514737
[TBL] [Abstract][Full Text] [Related]
20. The integrin αL leg region controls the Mg/EGTA mediated activation of LFA-1.
Guan S; Cheng M; Law SK
Biochem Biophys Res Commun; 2015 Mar; 458(2):251-5. PubMed ID: 25640842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
